HIF1A and coronary artery disorder: Combining HOTAIR with other lncRNAs that have been associated with CAD, such as APO1, HIF1A-AS2, and GAS5, may constitute a novel diagnostic and therapeutic strategy for treating CAD [29,38].This study has several limitations.